中文 | English
Return
Total: 5592 , 1/560
Show Home Prev Next End page: GO
Author:(Shu WANG)

1.Anti-thyroid drugs—first choice for Graves' disease

Shu WANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry

Shuling WANG ; Shu WANG

China Pharmacy 2005;0(16):-

3.Clinical Evaluation of the Level of Serum CA125 for Hepatic Functional Lesion in Patients with Cirrhosis

Donghai ZHANG ; Shu WANG

Journal of Medical Research 2006;0(07):-

4.Immunoregulation of radix tanshinone on isolated-lung preservation

Yongjian WANG ; Ping SHU

Chinese Journal of Primary Medicine and Pharmacy 2008;15(5):705-706

5.Treatment of Lumbar Disc Herniation with Intervertbral Disc Version Operation

Shu HUANG ; Weigang WANG

International Journal of Traditional Chinese Medicine 2009;31(3):209-211

6.Toll-like receptors and bacterial infection

Shu ZHANG ; Huiqin WANG

International Journal of Pediatrics 2014;(5):523-526

7.The measurement of convergence angles of the fixed denture

Shu JIANG ; Zhongyi WANG

Journal of Practical Stomatology 2001;17(2):138-140

8.Analysis of Clinical and Pathological Characteristics and Prognosis in 21 Children with Primary Focal Segmental Glomerulosclerosis

shu, TENG ; mo, WANG

Journal of Applied Clinical Pediatrics 1992;0(05):-

9.Current advance in genetics and clinical phenotype of Leber congenital amaurosis

Shu-ran, WANG

Chinese Journal of Experimental Ophthalmology 2013;31(12):1178-1182

10.CSI:New Factor for Marketing Competition of Pharmaceutical Enterprises

Shu WANG ; Wenzhan YANG

China Pharmacy 1991;0(01):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5592 , 1/560 Show Home Prev Next End page: GO